The latest global regulatory news, changes and updates affecting biopharma, including: WHO maps end of the road for some tropical diseases; MHRA updates import licensing guidance.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alzecure, Apollomics, Bavarian Nordic, Halozyme, Janssen, Mycovia, Neonmind, Valeo, Vasomune.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aligos, Amcure, Annovis, Astrazeneca, Atara, BMS, CCT, Cherry, Curevac, Esperion, Greenwich, Handl, Hinova, ICER, Incyte, Jubilant, Kiadis, Morphosys, Nanobiotix, Novartis, Noxopharm, Onethree, Pluristyx, Sareum, Selva, Sierra, Triplet, Tufts, UCB, Vaxart, Vistagen, Wuxi, Xencor, Xilio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AM-Pharma, Astrazeneca, Cardior, CG, CNS, Denovo, Effector, Epygenix, GSK, Inhibrx, Kahr, Medicago, Maat, Moderna, Organicell, Selva, Tissuetech, Wize.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA warning letter to company promoting test kits.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptive Biotechnologies, Beyond Air, Co-Diagnostics, Csa Medical, Dialco, Exuma Biotech, Fh Ortho, Garmin, Glaxosmithkline, Lumen, Olympus, Qiagen, Raysearch, Solace Therapeutics, Spectral Medical, Spine Innovations Stryker, Sumitomo, Wright Medical.

The latest global regulatory news, changes and updates affecting biopharma, including: MHRA advises on minimizing trial disruptions.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angiocrine, Bioxcel, Gyroscope, Inventiva, Sebela, Sorrento, Surface.